- Home
- EXEL vs RCI Comparison
EXEL vs RCI Comparison
Compare EXEL & RCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- RCI
- Stock Information
- Founded
- EXEL 1994
- RCI 1960
- Country
- EXEL United States
- RCI Canada
- Employees
- EXEL N/A
- RCI N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- RCI Cable & Other Pay Television Services
- Sector
- EXEL Health Care
- RCI Telecommunications
- Exchange
- EXEL Nasdaq
- RCI Nasdaq
- Market Cap
- EXEL 9.8B
- RCI 13.4B
- IPO Year
- EXEL 2000
- RCI N/A
- Fundamental
- Price
- EXEL $36.73
- RCI $25.75
- Analyst Decision
- EXEL Buy
- RCI Buy
- Analyst Count
- EXEL 18
- RCI 4
- Target Price
- EXEL $37.59
- RCI $67.00
- AVG Volume (30 Days)
- EXEL 2.3M
- RCI 1.1M
- Earning Date
- EXEL 05-13-2025
- RCI 04-23-2025
- Dividend Yield
- EXEL N/A
- RCI 5.57%
- EPS Growth
- EXEL 170.77
- RCI 196.65
- EPS
- EXEL 1.76
- RCI 2.26
- Revenue
- EXEL $2,168,701,000.00
- RCI $14,386,892,540.00
- Revenue This Year
- EXEL $5.78
- RCI $4.33
- Revenue Next Year
- EXEL $10.94
- RCI $2.20
- P/E Ratio
- EXEL $20.74
- RCI $11.25
- Revenue Growth
- EXEL 18.50
- RCI 1.50
- 52 Week Low
- EXEL $20.14
- RCI $23.18
- 52 Week High
- EXEL $40.26
- RCI $41.84
- Technical
- Relative Strength Index (RSI)
- EXEL 49.28
- RCI 51.46
- Support Level
- EXEL $34.90
- RCI $25.27
- Resistance Level
- EXEL $40.26
- RCI $25.84
- Average True Range (ATR)
- EXEL 1.18
- RCI 0.52
- MACD
- EXEL -0.13
- RCI 0.12
- Stochastic Oscillator
- EXEL 40.67
- RCI 74.83
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About RCI Rogers Communication Inc.
Rogers Communications is the largest wireless service provider in Canada, with its more than 11 million subscribers equating to one third of the total Canadian market. Its wireless business accounted for more than half of total revenue and has increasingly been providing a bigger portion of total company sales over the last several years. Rogers' cable segment, which provides about 35% of total revenue after acquiring Shaw, offers home internet, television, and landline phone service to consumers and businesses. Remaining sales come from Rogers' media unit, which owns and operates various television and radio stations and the Toronto Blue Jays. Rogers' significant exposure to sports also includes ownership stakes in the Toronto Maple Leafs, Raptors, FC, and Argonauts.